This study has been performed in diabetic type 2 patients with pain due to peripheral artery disease (PAD) in order to evaluate the efficacy and tolerability of tapentadol prolonged release (PR).
Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes / Anna Tedeschi, Alessandra De Bellis, Piergiorgio Francia, Arianna Bernini, Marco Perini, Elisabetta Salutini, Roberto Anichini. - In: JOURNAL OF DIABETES RESEARCH. - ISSN 2314-6745. - ELETTRONICO. - 2018:(2018), pp. 1-6.
Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes
Piergiorgio Francia
;Roberto Anichini
2018
Abstract
This study has been performed in diabetic type 2 patients with pain due to peripheral artery disease (PAD) in order to evaluate the efficacy and tolerability of tapentadol prolonged release (PR).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
